Assembly Biosciences, Inc.
ASMB
$32.87
-$2.41-6.83%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 57.52% | -141.10% | 340.21% | 9.83% | -15.65% |
| Total Depreciation and Amortization | -23.08% | -18.75% | 0.00% | 0.00% | -3.03% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 248.59% | -36.33% | -33.17% | 85.16% | 59.34% |
| Change in Net Operating Assets | 0.54% | -55.69% | -20.81% | 0.67% | 51.81% |
| Cash from Operations | 29.91% | -255.21% | 194.08% | 9.70% | 28.50% |
| Capital Expenditure | 100.00% | 20.83% | 42.86% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,616.97% | -125.24% | 113.43% | -1,031.09% | 158.03% |
| Cash from Investing | -1,610.91% | -125.36% | 113.41% | -1,031.33% | 158.03% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 72,876.51% | -67.32% | -99.73% | 48,060.22% | -81.43% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 72,876.51% | -67.32% | -99.73% | 48,060.22% | -81.43% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 104.27% | -176.09% | 2,539.95% | -348.23% | 103.97% |